Back

Immune checkpoint therapy in atherosclerosis.

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Anti-inflammatory Therapies for Atherosclerosis: Which Cells To Target? Basic Science, Other ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Esther Lutgens

Mayo Clinic, Rochester (United States of America)

1 More presentation in this session

Presentation thumbnail
The ins and outs of neutrophils in atherosclerosis.
Professor O. Soehnlein (Munich, DE)
Slides Video

Access the full session

Session thumbnail
Anti-inflammatory Therapies for Atherosclerosis: Which Cells To Target?

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Webinar
Recent advances in immune pathways in atherosclerosis
21 April 2021
thumbnail
Congress Presentation
The cardiotoxic potencial of immune checkpoint inhibitors: insights from a Cardio-Oncology clinic
21 June 2025
thumbnail
Congress Presentation
Circulating LIGHT/TNFSF14 levels are negatively associated with cardiovascular mortality, while intra-plaque levels are associated with symptomatic cerebrovascular disease
13 April 2024
thumbnail
Congress Presentation
Arterial inflammation induced by immune checkpoint inhibitors assessed on 18F-FDG PET-CT scans in stage III/IV melanoma patients
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources